Skip to main content
Figure 2 | Journal of Hematology & Oncology

Figure 2

From: Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)

Figure 2

Effect of time taken to become minimal residual disease (MRD)-negative on disease-free survival (DFS). Patients who were MRD positive after induction and became MRD negative after consolidation chemotherapy C in the first course (n = 7) had a significantly worse DFS compared with patients who were MRD negative after induction chemotherapy A in the first course (n = 26) (69% vs. 29%, p = 0.004).

Back to article page